US Patent Issued to NATIONAL DEFENSE MEDICAL UNIVERSITY on Nov. 25 for "Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2',4'-difluorophenyl)-salicylanilide derivatives" (Taiwanese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,632, issued on Nov. 25, was assigned to NATIONAL DEFENSE MEDICAL UNIVERSITY (Taipei, Taiwan).

"Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2',4'-difluorophenyl)-salicylanilide derivatives" was invented by Shuk-Man Ka (Taipei, Taiwan), Hsu-shan Huang (Taipei, Taiwan) and Ann Chen (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention is in the field of molecular biology/pharmacology and provides methods of using a pharmaceutical composition of 5-(2',4'-difluorophenyl)-salicylanilide derivatives and their ring-fused analogs for inhibiting, reducing, or treating chronic kidney di...